Bio-Rad Laboratories Inc (BIO)

Debt-to-capital ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	1,199,100	1,198,710	1,198,380	1,198,000	1,197,700	1,197,270	1,196,940	1,196,740	10,514	10,600	10,779	10,901	12,258	12,241	12,200	12,205	13,579	437,808	437,680	437,600
Total stockholders’ equity	US$ in thousands	8,741,130	8,416,200	8,446,890	9,763,720	9,615,250	8,477,470	8,945,040	10,203,300	13,685,200	15,332,400	11,594,900	10,609,100	9,889,690	8,825,140	7,353,400	6,293,080	5,756,840	5,131,190	5,486,810	4,863,860
Debt-to-capital ratio		0.12	0.12	0.12	0.11	0.11	0.12	0.12	0.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.08	0.07	0.08

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $1,199,100K ÷ ($1,199,100K + $8,741,130K)
= 0.12

The debt-to-capital ratio of Bio-Rad Laboratories Inc. has remained relatively stable over the past eight quarters, ranging from 0.11 to 0.12. This indicates that the company's level of debt relative to its total capital structure has been consistent during this period. A low and stable debt-to-capital ratio suggests that Bio-Rad Laboratories Inc. is managing its debt levels effectively and may have a conservative approach to financing its operations. Monitoring this ratio over time can provide insight into the company's financial health and risk management strategies.